IDEXX Laboratories Inc
IDXX700.550USD
-3.650-0.52%
Handelsschluss 12/15, 16:00（ET）Kurse um 15 Minuten verzögert
56.04BMarktkapitalisierung
55.13KGV TTM
mehr Informationen über IDEXX Laboratories Inc Unternehmen
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX Laboratories Inc Informationen
BörsenkürzelIDXX
Name des UnternehmensIDEXX Laboratories Inc
IPO-datumJun 21, 1991
CEOEmerson (Andrew)
Anzahl der mitarbeiter11000
WertpapierartOrdinary Share
GeschäftsjahresendeJun 21
AddresseOne Idexx Drive
StadtWESTBROOK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl04092-2041
Telefon12075560300
Websitehttps://www.idexx.com/
BörsenkürzelIDXX
IPO-datumJun 21, 1991
CEOEmerson (Andrew)
Führungskräfte von IDEXX Laboratories Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
Andere
-697.43M
-62.86%
Nach RegionUSD
Name
Umsatz
Anteil
United States
717.87M
64.70%
Europe & Middle East & Africa (EMEA) (Region)
233.27M
21.03%
Asia Pacific
89.30M
8.05%
Canada
46.69M
4.21%
Latin America
22.33M
2.01%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
Andere
-697.43M
-62.86%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.43%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
Andere
70.21%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.43%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
Andere
70.21%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
53.77%
Investment Advisor/Hedge Fund
30.95%
Research Firm
3.98%
Pension Fund
2.91%
Bank and Trust
1.86%
Individual Investor
0.69%
Sovereign Wealth Fund
0.59%
Hedge Fund
0.54%
Family Office
0.50%
Andere
4.22%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
9.84M
12.3%
+19.20K
+0.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.30M
6.63%
-132.86K
-2.44%
Jun 30, 2025
State Street Investment Management (US)
3.55M
4.44%
-95.45K
-2.62%
Jun 30, 2025
Fundsmith LLP
2.64M
3.3%
-9.04K
-0.34%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.46M
3.08%
+54.40K
+2.26%
Jun 30, 2025
Baron Capital Management, Inc.
2.03M
2.54%
-27.16K
-1.32%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
1.65M
2.06%
-5.80K
-0.35%
Aug 31, 2025
Principal Global Investors (Equity)
1.13M
1.41%
+1.75K
+0.16%
Jun 30, 2025
Polen Capital Management, LLC
1.20M
1.49%
+1.12M
+1519.07%
Jun 30, 2025
Walter Scott & Partners Ltd.
756.69K
0.95%
+597.11K
+374.18%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
Mehr Anzeigen
ProShares Pet Care ETF
Anteil9.4%
iShares U.S. Medical Devices ETF
Anteil4.42%
First Trust Water ETF
Anteil3.98%
SMI 3Fourteen Full-Cycle Trend ETF
Anteil3.9%
Nuveen ESG Mid-Cap Growth ETF
Anteil3.47%
Adaptive Core ETF
Anteil2.61%
First Trust S&P 500 Economic Moat Index ETF
Anteil2.25%
Acruence Active Hedge US Equity ETF
Anteil2.18%
Tema Durable Quality ETF
Anteil2.1%
Putnam Sustainable Future ETF
Anteil2.03%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von IDEXX Laboratories Inc?
Die fünf größten Anteilseigner von IDEXX Laboratories Inc sind:
The Vanguard Group, Inc. hält 9.84M Aktien, was 12.30% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 5.30M Aktien, was 6.63% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 3.55M Aktien, was 4.44% der Gesamtaktien entspricht.
Fundsmith LLP hält 2.64M Aktien, was 3.30% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 2.46M Aktien, was 3.08% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 9.84M Aktien, was 12.30% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 5.30M Aktien, was 6.63% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 3.55M Aktien, was 4.44% der Gesamtaktien entspricht.
Fundsmith LLP hält 2.64M Aktien, was 3.30% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 2.46M Aktien, was 3.08% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von IDEXX Laboratories Inc?
Die drei wichtigsten Anteilseigner-Typen von IDEXX Laboratories Inc sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an IDEXX Laboratories Inc (IDXX)?
Mit Stand vom 2025Q3 halten 2319 Institutionen Anteile an IDEXX Laboratories Inc, mit einem Gesamtmarktwert von etwa 77.76M, was 97.19% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -2.54% gestiegen.
Was ist die größte Einnahmequelle von IDEXX Laboratories Inc?
Am FY2025Q2 erzielte das Geschäft mit CAG Diagnostics recurring revenue für IDEXX Laboratories Inc den höchsten Umsatz in Höhe von 878.00M, was 79.14% des Gesamtumsatzes entspricht.
